BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 10177268)

  • 1. Applying the performance improvement team concept to the medication order process.
    Pantaleo N; Talan M
    J Healthc Qual; 1998; 20(2):30-5. PubMed ID: 10177268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality improvement in the use of medications through a drug use evaluation service.
    Stevenson JG; Bakst CM; Zaran FK; Rybak MJ; Smolarek RT; Alexander MR
    Top Hosp Pharm Manage; 1992 Oct; 12(3):47-56. PubMed ID: 10128747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ASHP national survey of pharmacy practice in hospital settings: monitoring and patient education--2003.
    Pedersen CA; Schneider PJ; Scheckelhoff DJ
    Am J Health Syst Pharm; 2004 Mar; 61(5):457-71. PubMed ID: 15018223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prioritizing strategies for preventing medication errors and adverse drug events in pediatric inpatients.
    Fortescue EB; Kaushal R; Landrigan CP; McKenna KJ; Clapp MD; Federico F; Goldmann DA; Bates DW
    Pediatrics; 2003 Apr; 111(4 Pt 1):722-9. PubMed ID: 12671103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit.
    Leape LL; Cullen DJ; Clapp MD; Burdick E; Demonaco HJ; Erickson JI; Bates DW
    JAMA; 1999 Jul; 282(3):267-70. PubMed ID: 10422996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse events due to discontinuations in drug use and dose changes in patients transferred between acute and long-term care facilities.
    Boockvar K; Fishman E; Kyriacou CK; Monias A; Gavi S; Cortes T
    Arch Intern Med; 2004 Mar; 164(5):545-50. PubMed ID: 15006832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 10 targets for reducing adverse drug events. Institute for Healthcare Improvement.
    Qual Lett Healthc Lead; 1999 Mar; 11(3):13-25. PubMed ID: 10351585
    [No Abstract]   [Full Text] [Related]  

  • 8. Multifaceted approach to reducing preventable adverse drug events.
    Silverman JB; Stapinski CD; Churchill WW; Neppl C; Bates DW; Gandhi TK
    Am J Health Syst Pharm; 2003 Mar; 60(6):582-6. PubMed ID: 12659063
    [No Abstract]   [Full Text] [Related]  

  • 9. Information technology for detecting medication errors and adverse drug events.
    Anderson JG
    Expert Opin Drug Saf; 2004 Sep; 3(5):449-55. PubMed ID: 15335300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developing a proactive approach to medication error prevention.
    Joiner GA
    J Healthc Qual; 1994; 16(2):35-9; quiz 39-40, 52. PubMed ID: 10132204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ASHP national survey of pharmacy practice in hospital settings: monitoring and patient education--2006.
    Pedersen CA; Schneider PJ; Scheckelhoff DJ
    Am J Health Syst Pharm; 2007 Mar; 64(5):507-20. PubMed ID: 17322164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacy service practice in a Chinese tertiary hospital.
    Chen B; Huang JJ; Chen HF; Xu BM
    Drug Metab Pers Ther; 2015 Dec; 30(4):215-30. PubMed ID: 26457791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacy's role in quality assurance of medication administration.
    Demers RF; Moore TD
    Top Hosp Pharm Manage; 1988 Feb; 7(4):45-54. PubMed ID: 10314266
    [No Abstract]   [Full Text] [Related]  

  • 14. Medication errors in inpatient pharmacy operations and technologies for improvement.
    Kuiper SA; McCreadie SR; Mitchell JF; Stevenson JG
    Am J Health Syst Pharm; 2007 May; 64(9):955-9. PubMed ID: 17468151
    [No Abstract]   [Full Text] [Related]  

  • 15. Attitudes of pharmacists and nurses toward interprofessional relations and decentralized pharmaceutical services.
    Thompson DF; Kaczmarek ER; Hutchinson RA
    Am J Hosp Pharm; 1988 Feb; 45(2):345-51. PubMed ID: 3364434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A training medication errors room: simulate to better train health professionals].
    Joret-Descout P; Te Bonle F; Demange C; Bechet M; Da Costa M; Camus G; Bohand X
    J Pharm Belg; 2015 Jun; (2):10-9. PubMed ID: 26466505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collaborative pharmaceutical care in an Irish hospital: uncontrolled before-after study.
    Grimes TC; Deasy E; Allen A; O'Byrne J; Delaney T; Barragry J; Breslin N; Moloney E; Wall C
    BMJ Qual Saf; 2014 Jul; 23(7):574-83. PubMed ID: 24505112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The epidemiology of preventable adverse drug events: a review of the literature.
    von Laue NC; Schwappach DL; Koeck CM
    Wien Klin Wochenschr; 2003 Jul; 115(12):407-15. PubMed ID: 12918183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the pharmacy department in the prevention of adverse drug events: a survey of current practices.
    Lin B; Anderson LR
    Pharm Pract Manag Q; 1997 Apr; 17(1):10-6. PubMed ID: 10166240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescribing errors resulting in adverse drug events: how can they be prevented?
    Thürmann PA
    Expert Opin Drug Saf; 2006 Jul; 5(4):489-93. PubMed ID: 16774487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.